
FDA Approves Linvoseltamab to Treat R/R Multiple Myeloma
Linvoseltamab (Regeneron) has been approved by the FDA to treat adults with relapsed/refractory (R/R) multiple myeloma (MM) who have undergone at least 4 prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an …